GMDA - Gamida Cell - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

129.2M

Cash

54.08M

Avg Qtr Burn

-18.78M

Short % of Float

6.79%

Insider Ownership

20.74%

Institutional Own.

30.76%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Omidubicel (NiCord) Details Hematologic malignancies	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
GDA-201 Details Non-Hodgkin lymphoma, Multiple myeloma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.